Susan Y. Wu, MD
Department of Rad Onc Dept., Division of Radiation Oncology
About Dr. Susan Y. Wu
Dr. Susan Wu received her BA, magna cum laude, from Rice University. She subsequently received her MD with Distinction in Research from the University of Texas Southwestern Medical Center at Dallas, followed by residency in Radiation Oncology at the University of California San Francisco, where she also served as chief resident.
Dr. Wu strives to provide personalized and compassionate care to all of her patients. Her research interests include using imaging to guide therapeutic decisions, improving treatment outcomes for patients with relapsed or refractory disease, and minimizing the side effects of radiotherapy.
Present Title & Affiliation
Primary Appointment
Clinical Assistant Professor, Clinical Sciences Department, The University of Houston, Houston, TX
Assistant Professor, Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
Dual/Joint/Adjunct Appointment
Clinical Assistant Professor, Clinical Sciences Department, The University of Houston, Houston, TX
Assistant Professor, Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
Education & Training
Degree-Granting Education
| 2015 | University of Texas Southwestern Medical Center at Dallas, Dallas, Texas, US, MD |
| 2010 | Rice University, Houston, Texas, US, Economics and Biological Sciences, BA |
Postgraduate Training
| 2016-2020 | Clinical Residency, Radiation Oncology, University of California, San Francisco, California |
| 2015-2016 | Clinical Internship, Internal Medicine, Texas Health Presbyterian Hospital, Dallas, Texas |
Licenses & Certifications
| 2021 | American Board of Radiology |
| 2020 | Texas Medical Board |
| 2016 | California Medical License |
Experience & Service
Other Professional Positions
Chief Resident, University of California San Francisco, San Francisco, CA, 2018 - 2019
Medical Student Clerkship Coordinator, University of California San Francisco, San Francisco, CA, 2017 - 2018
Intramural Institutional Committee Activities
Lymphoma Clinical Lead, Technology Assessment Committee, The University of Texas MD Anderson Cancer Center, 2025 - Present
Hematologic Malignancies Section Faculty Liaison, Division of Radiation Oncology Quality and Safety Committee, The University of Texas MD Anderson Cancer Center, 2022 - Present
New Technology Committee Member, MIM Working Group, The University of Texas MD Anderson Cancer Center, 2022 - Present
CoDirector, Assistant Research Coordinator Program, The University of Texas MD Anderson Cancer Center, 2022 - Present
Member, Resident and Fellow Council, The University of California, San Francisco, 2018 - 2019
Member, Diversity Committee, The University of California, San Francisco, 2018 - 2019
Member, Residency Selection Committee, The University of California, San Francisco, 2018 - 2019
Extramural Institutional Committee Activities
Member, AUC Steering Committee, American Radium Society, 2026 - Present
Vice-Chair, Appropriate Use Committee for Lymphoma, American Radium Society, 2026 - Present
Member, Writing Committee: 2027 revision of the ACR-ARS Practice Parameter for the Performance of Total Body Irradiation, American Radium Society, 2026 - 2027
Member, PhD Review Committee: Hennes Tsang, The University of Queensland, 2026
Member, Hematologic Malignancies Track Review Committee, American Society of Radiation Oncology (ASTRO), 2026
Member, Appropriate Use Committee for Lymphoma, American Radium Society, 2025 - 2026
Honors & Awards
| 2026 | Mendy Jeter Excellence in Clinical Care Award, The University of Texas MD Anderson Cancer Center |
| 2026 | ARRO Educator of the Year |
| 2020 | Junior Brachytherapy Travel Grant, Elekta |
| 2019 | Roentgen Resident/Fellow Research Award, Radiologic Society of North America |
| 2019 | Multidisciplinary Thoracic Cancers Symposium Travel Grant |
| 2019 | Member-In-Training Outstanding Abstract Award, AAWR/ASTRO |
| 2018 | Clinical and Translational Science Institute Travel Award, University of California San Francisco |
| 2018 | Young Oncologist Essay Award, American Radium Society |
| 2017 | Conquer Cancer Foundation Merit Award, American Society of Clinical Oncology |
| 2014 | Alpha Omega Alpha Medical Honor Society |
| 2012 - 2013 | Doris Duke Clinical Research Fellowship, The University of Texas Southwestern Medical Center at Dallas, TX |
| 2009 | Loewenstern Fellowship, Rice University, Houston, TX |
| 2008 | Leadership Rice Summer Fellowship, Rice University, Houston, TX |
Professional Memberships
Selected Presentations & Talks
Local Presentations
- 2026. Aggressive Lymphoma / CAR-T Therapy. Invited. Network Education in Radiation Oncology 2026 Conference. Houston, Texas, US.
- 2020. Squamous Cell Carcinoma of Unknown Primary in the Head and Neck. Conference. Squamous Cell Carcinoma of Unknown Primary in the Head and Neck. San Francisco, CA, US.
- 2019. Radiation with 30 days of death: Improving treatment recommendations using a machine learning approach. Conference. Radiation with 30 days of death: Improving treatment recommendations using a machine learning approach. San Francisco, CA, US.
- 2019. Improved Gamma Knife End of Treatment Documentation. Conference. Improved Gamma Knife End of Treatment Documentation. San Francisco, CA, US.
- 2019. Nasopharyngeal Carcinoma. Conference. Nasopharyngeal Carcinoma. San Francisco, CA, US.
- 2018. Re-Irradiation for Glioblastoma. Conference. Re-Irradiation for Glioblastoma. San Francisco, CA, US.
- 2018. Primary CNS Lymphoma. Conference. Primary CNS Lymphoma. San Francisco, CA, US.
- 2017. Squamous Cell Carcinoma of the Oral Cavity. Conference. Squamous Cell Carcinoma of the Oral Cavity. San Francisco, CA, US.
- 2017. Post-op RT for Squamous Cell Carcinoma of the Head and Neck. Conference. Post-op RT for Squamous Cell Carcinoma of the Head and Neck. San Francisco, CA, US.
- 2017. Merkel Cell Carcinoma. Conference. San Francisco, CA, US.
- 2017. Esophageal and Gastric Cancer. Conference. Esophageal and Gastric Cancer. San Francisco, CA, US.
National Presentations
- 2024. Early Stage Classical Hodgkin Lymphoma. Invited. University of California San Francisco Medical Grand Rounds. San Francisco, CA, US.
- 2024. Early Stage Classical Hodgkin Lymphoma. Invited. University of California San Francisco Medical Grand Rounds. San Francisco, CA, US.
- 2023. Ultra Low-Dose Radiation for Extranodal Marginal Zone Lymphoma of the Lung. Conference. Ultra Low-Dose Radiation for Extranodal Marginal Zone Lymphoma of the Lung. San Diego, CA, US.
- 2022. Outcome of Patients with Central Nervous System Multiple Myeloma (CNS-MM) Treated with CNS-Directed Radiation Therapy. Conference. Outcome of Patients with Central Nervous System Multiple Myeloma (CNS-MM) Treated with CNS-Directed Radiation Therapy. San Antonio, TX, US.
- 2022. Radiotherapy in the Treatment of Primary Cutaneous CD4+ Small/Medium T-Cell Lymphoproliferative Disorder. Conference. Radiotherapy in the Treatment of Primary Cutaneous CD4+ Small/Medium T-Cell Lymphoproliferative Disorder. San Antonio, TX, US.
- 2022. Primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder requires a multidisciplinary approach. Conference. Primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder requires a multidisciplinary approach. Boston, MA, US.
- 2021. Radiation Therapy can be Safely Incorporated into Pre-Transplant Treatment Regimens for Patients with Multiple Myeloma. Conference. Radiation Therapy can be Safely Incorporated into Pre-Transplant Treatment Regimens for Patients with Multiple Myeloma. Chicago, IL, US.
- 2021. Poster: Concurrent Radiation Therapy with the Antibody-Drug Conjugates Brentuximab Vedotin and Polatuzumab Vedotin. Conference. Poster: Concurrent Radiation Therapy with the Antibody-Drug Conjugates Brentuximab Vedotin and Polatuzumab Vedotin. Chicago, IL, US.
- 2020. Classification of patients at imminent risk of death at the time of palliative radiotherapy consultation. Oral scientific session. Conference. Classification of patients at imminent risk of death at the time of palliative radiotherapy consultation. Oral scientific session. Miami, FL, US.
- 2019. Salvage High Dose Rate Brachytherapy for Recurrent Prostate Cancer after Definitive Radiation. Conference. Salvage High Dose Rate Brachytherapy for Recurrent Prostate Cancer after Definitive Radiation. Chicago, IL, US.
- 2019. The Impact of Structured, Prospective Exposure to the NCCN Guidelines when Making Treatment Decisions: Improved Metrics of Guideline-Concordant Care for Patients with Non-Small Cell Lung Cancer. Conference. The Impact of Structured, Prospective Exposure to the NCCN Guidelines when Making Treatment Decisions: Improved Metrics of Guideline-Concordant Care for Patients with Non-Small Cell Lung Cancer. San Diego, CA, US.
- 2018. Stereotactic radiosurgery for primary central nervous system lymphoma. Conference. Stereotactic radiosurgery for primary central nervous system lymphoma. New Orleans, LA, US.
- 2018. Emergent Palliative Radiotherapy: Dedicated Personnel Resources Improve Workflow. Conference. Emergent Palliative Radiotherapy: Dedicated Personnel Resources Improve Workflow. San Diego, CA, US.
- 2018. Patient Exposure to NCCN Guidelines: Impact on Decisional Conflict and Satisfaction with Decision. Conference. Patient Exposure to NCCN Guidelines: Impact on Decisional Conflict and Satisfaction with Decision. San Antonio, TX, US.
- 2017. Radiation within 30 Days of Death: TEACHH score and ability to complete treatment. Conference. Radiation within 30 Days of Death: TEACHH score and ability to complete treatment. San Diego, CA, US.
International Presentations
- 2026. High Quality palliative radiotherapy. Invited. ARS 2026 Annual Meeting.
- 2026. Education Session, Lymphoma, Sarcoma, Pediatrics. Invited. ARS 2026 Annual Meeting.
- 2025. Indications for Radiation Therapy in Leukemia: A Shifting Landscape. Invited. ASTRO's 2025 Annual Meeting.
Formal Peers
- 2017. Radiation Oncology: Treatment options and radiology needs. Invited. San Francisco, CA, US.
Selected Publications
Peer-Reviewed Articles
- Dandapani, SV, Ahmed, S, Robinson, TJ, Advani, RH, Bates, JE, Constine, LS, Dabaja, BS, Ha, CS, Hoppe, BS, Vega, RM, Peterson, JL, Pinnix, CC, Plastaras, JP, Shaaban, SG, Wu, SY, Milgrom, SA. Executive Summary of the American Radium Society Appropriate Use Criteria for Extranodal Natural Killer/T-cell Lymphoma. International Journal of Radiation Oncology Biology Physics 126(1):102-117, 2026. e-Pub 2026. PMID: 41785936.
- Damian-Jacobo EA, Chi X, Ludmir EB, Chino F, Lin R, Koay EJ, Lee A, Wu SY. Characteristics of Crowdfunding Campaigns for Proton Therapy. Int J Radiat Oncol Biol Phys, 2026. e-Pub 2026.
- Corrigan, KL, Berkman, AM, Gunther, J, Andersen, C, Wu, SY, Gibson, A, Cuglievan, B, Garcia, MB, Manzar, G, Fang, PQ, De, BS, Ahmed, S, Nunez, CA, Hildebrandt, MA, McCall, DC, Parsons, SK, Roth, M. Trends in Radiation Use from 2004 to 2020 among Adolescents and Young Adults with Hodgkin Lymphoma. Cancer Epidemiology Biomarkers and Prevention 34(9):1483-1491, 2025. e-Pub 2025. PMID: 40488452.
- Yegya-Raman, N, Plastaras, JP, Wright, C, Chelius, M, Zhang, S, Baron, J, Hubbeling, H, Sim, AJ, Robinson, TJ, Jain, MD, Imber, BS, Fregonese, B, Yahalom, J, Ladbury, C, Dandapani, SV, Pinnix, CC, Gunther, J, Fang, PQ, Wu, SY, Dabaja, BS, Yang, JC, Chew, J, Braunstein, SE, Sinha, S, Delinger, NM, Sun, S, Terezakis, SA, Sakthivel, G, Constine, LS, Chowdhry, AK, Reagan, P, Burke, S, Tseng, YD, LaRiviere, MJ, Maity, A, Schuster, SJ, Chong, EA, Figura, NB. Bridging radiotherapy before chimeric antigen receptor T cells for B-cell lymphomas. Blood Advances 9(13):3293-3303, 2025. e-Pub 2025. PMID: 40203192.
- Manzar, G, Dudzinski, SO, Yoder, A, Seo, A, Nasr, L, Rafei, H, Becnel, M, Patel, K, Lee, HC, Kaufman, GP, Gaballa, MM, Ye, JC, Saini, N, Thomas, SK, Amini, B, Orlowski, R, Dabaja, BS, Pinnix, CC, Gunther, J, Wu, SY, Fang, PQ. Outcome of Patients With Central Nervous System Multiple Myeloma (CNS-MM) Treated With CNS-Directed Radiation Therapy. Clinical Lymphoma, Myeloma and Leukemia 25(4):271-284, 2025. e-Pub 2025. PMID: 39709251.
- Manzar, G, Wu, SY, Dudzinski, SO, Cha, E, Yoder, A, Corrigan, KL, Nasr, L, Sallard, G, Ahmed, S, Fayad, LE, Chihara, D, Nair, R, Westin, JR, Daher, M, Neelapu, SS, Nastoupil, L, Gunther, J, Pinnix, CC, Dabaja, BS, Strati, P, Fang, PQ. Characterization of Lymphopenia and Correlating the Risk of Cytopenias With Dose and Bone Marrow Volume Irradiated in Aggressive B Cell Lymphoma Patients Bridged With Radiation Therapy for Chimeric Antigen Receptor-T Cell Therapy. International Journal of Radiation Oncology Biology Physics 121(4):1011-1025, 2025. e-Pub 2025. PMID: 39303997.
- Wu, SY, Damron, EP, Xu, J, Fang, PQ, Dai, J, Nair, R, Malpica Castillo, LE, Fayad, LE, Torres Cabala, CA, Medeiros, LJ, Vega Vazquez, F, Miranda, R, Duvic, M, Pinnix, CC, Dabaja, BS, Iyer, S, Huen, A, Gunther, J. Radiotherapy in the treatment of primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder. Int J Dermatol 64(2):385-389, 2025. e-Pub 2025. PMID: 38955474.
- Manzar, G, Pinnix, CC, Dudzinski, SO, Marqueen, KE, Cha, E, Nasr, L, Yoder, A, Rooney, MK, Strati, P, Ahmed, S, Nze, CC, Nair, R, Fayad, LE, Wang, L, Nastoupil, L, Westin, JR, Flowers, CR, Neelapu, SS, Gunther, J, Dabaja, BS, Wu, SY, Fang, PQ. Outcomes with bridging radiation therapy prior to chimeric antigen receptor T-cell therapy in patients with aggressive large B-cell lymphomas. Frontiers in immunology 16, 2025. e-Pub 2025. PMID: 39958356.
- Wu, SY, Fang, PQ, Fetooh, A, Manzar, G, Corrigan, KL, Schrank, BR, Nasr, L, Chihara, D, Castillo, LM, Nair, R, Steiner, RE, Jain, P, Neelapu, SS, Strati, P, Nastoupil, L, Dabaja, BS, Pinnix, CC, Gunther, J. Ultra–Low-Dose Radiation for Extranodal Marginal Zone Lymphoma of the Lung. Advances in Radiation Oncology 9(12), 2024. e-Pub 2024. PMID: 39524525.
- Fang, PQ, Noticewala, SS, Wu, SY, Gunther, J, Ludmir, EB, Medeiros, LJ, Strati, P, Nair, R, Nze, CC, Nastoupil, L, Ahmed, S, Castillo, LM, Fayad, LE, Westin, J, Neelapu, SS, Flowers, CR, Huen, A, Iyer, SP, Dabaja, BS, Pinnix, CC. Early-Stage Extranodal NK/T-Cell Lymphoma, Nasal Type. Advances in Radiation Oncology 9(12), 2024. e-Pub 2024. PMID: 39553398.
- Kahn J, Dabaja B, Wu S, Kelly K, Berkahn L, Pavlovsky A, Sureda A, LaCasce A. Classic Hodgkin lymphoma. Hematol Oncol 42(6), 2024. e-Pub 2024. PMID: 38037872.
- Pinnix, CC, Dabaja, BS, Gunther, J, Fang, PQ, Wu, SY, Nastoupil, L, Strati, P, Nair, R, Ahmed, S, Steiner, RE, Westin, JR, Neelapu, SS, Rodriguez, MA, Lee, HJ, Wang, L, Flowers, CR, Feng, L, Esmaeli, B. Response-Adapted Ultralow-Dose Radiation Therapy for Orbital Indolent B-Cell Lymphoma. JAMA Oncology 10(9):1195-1203, 2024. e-Pub 2024. PMID: 38990564.
- Zhang JR, Wu SY, Jain P, Ok CY, Yan F, Chen W, Oriabure O, Dabaja B, Gunther J, Fang P, Pinnix C, Wang ML, Gaulin C. Characteristics, treatment, and outcomes of mantle cell lymphoma with cutaneous involvement. Leuk Lymphoma 65(11), 2024. PMID: 38972059.
- Gunther, J, Xu, J, Bhutani, M, Strati, P, Fang, PQ, Wu, SY, Dabaja, BS, Dong, W, Bhosale, PR, Flowers, CR, Nair, R, Malpica Castillo, LE, Fayad, LE, Iyer, S, Parmer, S, Wang, ML, Lee, HJ, Samaniego, F, Westin, JR, Ahmed, S, Nze, CC, Jain, P, Neelapu, SS, Rodriguez, MA, Chihara, D, Nastoupil, L, Pinnix, CC. Response-adapted ultra-low-dose 4 Gy radiation as definitive therapy of gastric MALT lymphoma. The Lancet Haematology 11(7):e521-e529, 2024. e-Pub 2024. PMID: 38843856.
- Fang P, Pinnix CC, Wu SY, Lee HC, Patel KK, Saini N, Becnel MR, Kaufman G, Thomas SK, Orlowski RZ, Amini B, Lin P, Dabaja BS, Gunther JR. Management and Outcomes of Patients with Refractory Solitary Plasmacytoma after Treatment with Definitive Radiation Therapy. Int J Radiat Oncol Biol Phys 119(1):193-199, 2024. e-Pub 2024. PMID: 38070713.
- Manzar, G, Cha, E, Corrigan, KL, Yoder, A, Schrank, BR, Nasr, L, Chihara, D, Castillo, LM, Nair, R, Jain, P, Neelapu, SS, Rodriguez, MA, Strati, P, Nastoupil, L, Gunther, J, Dabaja, BS, Pinnix, CC, Wu, SY, Fang, PQ. Outcomes and toxicities in patients with diffuse-large B cell lymphoma involving the gastrointestinal tract and digestive organs. Frontiers in Oncology 14, 2024. e-Pub 2024. PMID: 39324011.
- Steiner RE, Hwang SR, Khurana A, Habermann TM, Epperla N, Annunzio K, Allen PB, Baird K, Paulino D, Alderuccio JP, Lossos IS, David K, Evens AM, Pandya K, Bair SM, Kamdar M, Ba Aqeel S, Torka P, Lynch R, Smith S, Feng L, Noorani M, Ahmed S, Nair R, Vega F, Wu S, Fang P, Pinnix CC, Gunther JR, Dabaja BS, Lee HJ. Impact of Cumulative Dose of Brentuximab Vedotin on Outcomes of Frontline Therapy for Advanced Stage Hodgkin Lymphoma. Blood Adv 7(24):7485-7493, 2023. e-Pub 2023. PMID: 37603594.
- Wu SY, Braunstein SE, Rubenstein JL, Sneed PK. Stereotactic Radiosurgery for Primary Central Nervous System Lymphoma. Cureus 15(2):e34817, 2023. e-Pub 2023. PMID: 36915845.
- Damron, EP, Qazilbash, MH, Fang, PQ, Wu, SY, Dabaja, BS, Rondon, G, Hosing, C, Champlin, RE, Bashir, Q, Shpall, E, Knafl, M, Lee, HC, Manasanch, EE, Patel, K, Thomas, SK, Orlowski, R, Weber, DM, Pinnix, CC, Gunther, J. Radiation Therapy Can Be Safely Incorporated into Pretransplantation Treatment Regimens for Patients with Multiple Myeloma. Transplantation and Cellular Therapy 29(1):37.e1-37.e7, 2023. e-Pub 2023. PMID: 37753818.
- Wu SY, Fang PQ, Wang EB, Ahmed S, Duvic M, Jain P, Castillo LEM, Nair R, Steiner RE, Strati P, Huen AO, Iyer SP, Pinnix CC, Dabaja BS, Gunther JR. Safety of Concurrent Radiation Therapy with Brentuximab Vedotin in the Treatment of Lymphoma. Adv Radiat Oncol 8(6):101279, 2023. e-Pub 2023. PMID: 37448588.
- Wu SY, Short NJ, Nasr L, Dabaja BS, Fang PQ. Central Nervous System Prophylaxis and Treatment in Acute Leukemias. Curr Treat Options Oncol 23(12):1829-1844, 2022. e-Pub 2022. PMID: 36510037.
- Champlin RE, Lustig EB, Bashir Q, Oran B, Kornblau SM, Hosing C, Alousi AM, Popat U, McCarty JM, Thall P, Dabaja BS, Liu WH, Dang G, Castro K, Ramirez A, Spiotto M, Wu S, Fang P, Kaur I, Rezvani K, Cooper L, Reisner Y. First in Human Study of Anti-Viral Veto Cells Enabling Successful Engraftment without Severe Gvhd in Non-Myeloablative T Cell Depleted Haploidentical Hematopoietic Stem Cell Transplantation (HSCT). Blood 140(Supl 1):2120-2122, 2022. e-Pub 2022.
- Damron EP, Qazillbash MH, Fang P, Wu SY, Dabaja BS, Rondon G, Hosing C, Champlin RE, Bashir Q, Shpall EJ, Knafl MK, Lee HC, Manasanch EE, Patel K, Thomas SK, Orlowski RZ, Weber DM, Pinnix CC, Gunther JR. Radiation therapy can be safely incorporated into pretransplantation treatment regimens for patients with multiple myeloma. Transplant Cell Ther 29(1):E1-37, 2022. e-Pub 2022.
- Wu SY, Pinnix CC. Chemoradiation to Improve Local Control, and Thereby Overall Survival for Limited Stage Nasal NKTCL. Int J Radiat Oncol Biol Phys 111(5):1105-1106, 2021. e-Pub 2021. PMID: 34793730.
- Wu SY, Yee E, Vasudevan HN, Fogh SE, Boreta L, Braunstein SE, Hong JC. Risk Stratification for Imminent Risk of Death at the Time of Palliative Radiotherapy Consultation. JAMA Netw Open 4(7):e2115641, 2021. e-Pub 2021. PMID: 34196716.
- Wu SY, Wong AC, Shinohara K, Roach M, Cunha JAM, Valdes G, Hsu IC. Machine Learning Analysis of Salvage HDR Prostate Brachytherapy-A Validation Study. Practical Radiation Oncology 11(6):515-526, 2021. e-Pub 2021.
- Wu SY, Yee E, Chan JW, Chapman CH, Boreta L, Braunstein SE. Timing of Urgent Inpatient Palliative Radiation Therapy. Adv Radiat Oncol 6(3):100670, 2021. e-Pub 2021. PMID: 33817413.
- Fang PQ, Gunther JR, Wu SY, Dabaja BS, Nastoupil LJ, Ahmed S, Neelapu SS, Pinnix CC. Radiation and CAR T-cell Therapy in Lymphoma: Future Frontiers and Potential Opportunities for Synergy. Front Oncol 11:648655, 2021. e-Pub 2021. PMID: 33842363.
- Wu SY, Wong AC, Shinohara K, Roach M, Cunha JAM, Valdes G, Hsu IC. Salvage high dose rate brachytherapy for recurrent prostate cancer after definitive radiation. Pract Radiat Oncol 11(6):515-526, 2021. e-Pub 2021. PMID: 34077809.
- Wu SY, Lazar AA, Gubens MA, Blakely CM, Gottschalk AR, Jablons DM, Jahan TM, Wang VEH, Dunbar TL, Wong ML, Chan JW, Guthrie W, Belkora J, Yom SS. Evaluation of a National Comprehensive Cancer Network Guidelines-Based Decision Support Tool in Patients with Non-Small Cell Lung Cancer: A Nonrandomized Clinical Trial. JAMA Netw Open 3(9):e209750, 2020. e-Pub 2020. PMID: 32997124.
- Dabaja B, Milgrom S, Parikh R, Wu S, Tsang R. The challenges of applying radiation in primary central nervous system lymphoma. Int J Radiat Oncol Biol Phys 107(3):398-400, 2020. e-Pub 2020. PMID: 32531380.
- Wu SY. Consolidative Whole Brain Radiation for Those with Residual Disease, Reserving Focal Radiation for Salvage. Int J Radiat Oncol Biol Phys 107(3):401-402, 2020. e-Pub 2020. PMID: 32531382.
- Wu SY, Sath C, Schuster JM, Dominello MM, Burmeister JW, Golden DW, Braunstein SE. Targeted Needs Assessment of Treatment Planning Education for United States Radiation Oncology Residents. Int J Radiat Oncol Biol Phys 106(4):677-682, 2020. e-Pub 2020. PMID: 31786277.
- Hohenstein NA, Chan JW, Wu SY, Tahir P, Yom SS. Diagnosis, Staging, Radiation Treatment Response Assessment, and Outcome Prognostication of Head and Neck Cancers Using PET Imaging: A Systematic Review. PET Clin 15(1):65-75, 2020. e-Pub 2020. PMID: 31735303.
- Wu SY, Yom SS. Current Standards for Organ Preservation in Locoregionally Advanced Non-Nasopharyngeal Head and Neck Cancer and Evolving Strategies for Favorable-Risk and Platinum-Ineligible Populations. Curr Treat Options Oncol 20(12):89, 2019. e-Pub 2019. PMID: 31797157.
- Xu MJ, Kornberg Z, Gadzinski AJ, Diao D, Cowan JE, Wu SY, Boreta L, Spratt DE, Behr SC, Nguyen HG, Cooperberg MR, Davicioni E, Roach M, Hope TA, Carroll PR, Feng FY. Genomic Risk Predicts Molecular Imaging-detected Metastatic Nodal Disease in Prostate Cancer. Eur Urol Oncol 2(6):685-690, 2019. e-Pub 2019. PMID: 31411984.
- Morshed RA, Wu SY, Sneed PK, McDermott MW. Radiotherapy for recurrent intracranial epidermoid cysts without malignant transformation: A single-institution case series. J Neurooncol 144(1):89-96, 2019. e-Pub 2019. PMID: 31168670.
- Boreta L, Gadzinski AJ, Wu SY, Xu M, Greene K, Quanstrom K, Nguyen HG, Carroll PR, Hope TA, Feng FY. Location of Recurrence by Gallium-68 PSMA-11 PET Scan in Prostate Cancer Patients Eligible for Salvage Radiotherapy. Urology 129:165-171, 2019. e-Pub 2019. PMID: 30928607.
- Wu SY, Boreta L, Shinohara K, Nguyen H, Gottschalk AR, Hsu IC, Roach M, Westphalen AC, Feng FY, Carroll PR, Chang AJ, Hope TA. Impact of Staging 68Ga-PSMA-11 PET Scans on Radiation Treatment Plansin Patients with Prostate Cancer. Urology 125:154-162, 2019. e-Pub 2019. PMID: 30580002.
- Wu SY, Singer L, Boreta L, Garcia MA, Fogh SE, Braunstein SE. Palliative radiotherapy near the end of life. BMC Palliat Care 18(1):29, 2019. e-Pub 2019. PMID: 30904024.
- Cooksey R, Wu SY, Klesse L, Oden JD, Bland RE, Hodges JC, Gargan L, Vega GL, Bowers DC. Metabolic syndrome is a sequela of radiation exposure in hypothalamic obesity among survivors of childhood brain tumors. J Investig Med 67(2):295-302, 2019. e-Pub 2019. PMID: 30530528.
- Wu SY, Boreta L, Wu A, Cunha JAM, Shinohara K, Chang AJ. Improved rectal dosimetry with the use of SpaceOAR during high dose rate brachytherapy. Brachytherapy 17(2):259-264, 2018. e-Pub 2018.
- Wu SY, McCavit TL, Cederberg K, Galindo RL, Leavey PJ. Chemotherapy for Generalized Infantile Myofibromatosis with Visceral Involvement. J Pediatr Hematol Oncol 37(5):402-5, 2015. e-Pub 2015. PMID: 24608078.
Abstracts
- Manzar GS, Wu SY, Dudzinski SO, Jallouk A, Yoder AK, Nasr LF, Corrigan KL, Gunther JL, Ahmed S, Fayad L, Nair R, Steiner R, Westin J, Neelapu SS, Dabaja B, Strati P, Nastoupil L, Pinnix CC, Fang P, Rooney MK. Outcomes with Bridging Radiation Therapy Prior to CAR-T Cell Therapy in Pts with Aggressive B Cell Lymphomas. Int J Radiat Oncol Biol Phys 117(2S):e483-e484, 2023. e-Pub 2023. PMID: 39958356.
- Schrank BR, Manzar GS, Wu SY, Gunther JR, Fang P, Jabbour EJ, Lim TY, Daver NG, Cykowski MD, Fuller GN, Cachia D, Kamiya-Matsuoka C, Woodman KH, DiNardo CD, Jain N, Short NJ, Sasaki K, Dabaja B, Kantarjian HM, Pinnix CC. Dorsal Column Myelopathy Following Intrathecal Chemotherapy for Leukemia. Int J Radiat Oncol Biol Phys 117(2S):e486-e487, 2023. e-Pub 2023.
- Cha E, Manzar GS, Corrigan KL, Yoder AK, Schrank BR, Nasr LF, Gunther JR, Strati P, Ahmed S, Fayad L, Nair R, Steiner R, Westin J, Nastoupil L, Neelapu SS, Pinnix CC, Dabaja B, Wu SY, Fang P. Outcomes and Toxicities in Patients with Diffuse Large B-Cell Lymphoma of the Gastrointestinal Tract. Int J Radiat Oncol Biol Phys 117(2S):E460, 2023. e-Pub 2023.
- Wu SY, Gunther JR, Manzar GS, Corrigan KL, Damron EP, Schrank BR, Nasr LF, Chihara D, Malpica Castillo LE, Nair R, Steiner R, Jain P, Neelapu SS, Samanego F, Rodriguez MA, Strati P, Nastoupil L, Dabaja B, Pinnix CC, Fang P. Ultra Low-Dose Radiation for Extranodal Marginal Zone Lymphoma of the Lung. Int J Radiat Oncol Biol Phys 117(2S):e492, 2023. e-Pub 2023.
- Manzar GS, Wu SY, Dudzinski SO, Rooney MK, Jallouk A, Yoder AK, Nasr LF, Gunther JR, Sallard G, Ahmed S, Fayad L, Nair R, Steiner R, Westin J, Nastoupil L, Neelapu SS, Dabaja B, Pinnix CC, Strati P, Fang P. Characterization of Lymphopenia during Bridging Radiation Therapy Prior to CAR-T Cell Therapy in Patients with Aggressive B Cell Lymphomas. Int J Radiat Oncol Biol Phys 117(2S):S53-S54, 2023. e-Pub 2023.
- Khan M, Mohamed S, Becnel M, Thomas S, Manasanch E, Lee H, Iyer S, Qazilbash M, Bashir Q, Srour S, Wu S, Fang P, Gunther J, Pinnix C, Amini B, Lin P, Dabaja B, Patel K, Weber D, Orlowski RZ, Kaufman G. Central nervous system Multiple Myeloma (CNS-MM), presentation and outcomes in an Era of anti-CD38 and pomalidomide inclusive therapies. Clinical Lymphoma Myeloma & Leukemia 21(S146-S146), 2021. e-Pub 2021.
- Pinnix C, Damron E, Gunther J, Fang P, Wu S, Dabaja B, Neelapu S, Nastoupil L, Ahmed S, Strati P, Westin J, Fayad L, Steiner R, Nair R, Gombos D, Fowler N. Primary intraocular lymphoma: Outcomes and toxicity after radiation therapy. American Journal of Clinical Oncology-Cancer Clinical Trials 44(10):S29-S30, 2021. e-Pub 2021.
- Wu SY, Fang P, Huen AO, Iyer SP, Nair R, Steiner R, Castillo LEM, Duvic M, Ahmed S, Jain P, Fayad L, Strati P, Westin J, Neelapu SS, Nastoupil L, Pinnix CC, Dabaja B, Gunther JR. Concurrent Radiation Therapy with the Antibody-Drug Conjugates Brentuximab Vedotin and Polatuzumab Vedotin. Int J Radiat Oncol Biol Phys 111(3S):e301, 2021. e-Pub 2021.
- Boreta L, Yee E, Wu SY, Braunstein SE. Whole-brain radiation practice pattern at a tertiary hospital with high-volume radiosurgery practice. Journal of Clinical Oncology 37(31 Suppl):113, 2019. e-Pub 2019.
- Wu SY, Boreta L, Chan J, Chapman CH, Yee E, Braunstein SE. Emergent palliative radiotherapy: Dedicated personnel resources to improve workflow. J Clin Oncol 36(34 Suppl):93, 2018. e-Pub 2018.
- Wu SY, Boreta L, Shinohara K, Nguyen H, Carroll P, Westphalen A, Hope T, Chang AJ. Impact of Staging 68Ga-PSMA-11 Pet Scans on Radiation Treatment Plans in Patients with Prostate Cancer. Int J Radiat Oncol Biol Phys 101(2, Suppl 1):e15, 2018. e-Pub 2018.
Book Chapters
- Wu, SY, Dabaja, BS, Fang, PQ. Radiobiologic Principles and the Role of Radiotherapy in Hematopoietic Cell Transplant and Chimeric Antigen Receptor T-Cell Therapy. In: Manual of Hematopoietic Cell Transplantation and Cellular Therapies. Elsevier, 167-179, 2023.
- Wu SY, Yom SS. Deintensification of treatment for HPV-associated cancers of the oropharynx. In: Textbook of Oral Cancer: Prevention, Diagnosis and Management. 1st. King’s College London, 2020.
- Wu SY, Fang PQ, Dabaja BS. Role of radiation therapy in HCT and CAR therapies. In: Manual of Stem Cell Transplantation and Cellular Therapies for Hematologic Malignancies.
Patient Reviews
CV information above last modified August 25, 2026